Angiotensin II Produces Nociceptive Behavior through Spinal AT1 Receptor-Mediated p38 Mitogen-Activated Protein Kinase Activation in Mice

Molecular Pain - Tập 9 - 2013
Wataru Nemoto1, Osamu Nakagawasai1, Fukie Niijima1, Syu‐ichi Kanno2, Shin Yomogida2, Masaaki Ishikawa2, Takeshi Tadano3, Koichi Tan–No1
1Department of Pharmacology, Tohoku Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan
2Department of Clinical Pharmacotherapeutics, Tohoku Pharmaceutical University, Aoba-ku, Sendai 981-8558, Japan
3Laboratory of Environmental and Health Sciences, College of Medical Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-1192, Japan

Tóm tắt

Background It has been demonstrated that angiotensin II (Ang II) participates in either the inhibition or the facilitation of nociceptive transmission depending on the brain area. Neuronal Ang II is locally synthesized not only in the brain, but also in the spinal cord. Though the spinal cord is an important area for the modulation of nociception, the role of spinal Ang II in nociceptive transmission remains unclear. Therefore, in order to elucidate the role of Ang II in nociceptive transmission in the spinal cord, we examined the effect of intrathecal (i.t.) administration of Ang II into mice. Results I.t. administration of Ang II produced a behavioral response in mice mainly consisting of biting and/or licking of the hindpaw and the tail along with slight hindlimb scratching directed toward the flank. The behavior induced by Ang II (3 pmol) was dose-dependently inhibited by intraperitoneal injection of morphine (0.1–0.3 mg/kg), suggesting that the behavioral response is related to nociception. The nociceptive behavior was also inhibited dose-dependently by i.t. co-administration of losartan (0.3–3 nmol), an Ang II type 1 (AT1) receptor antagonist, and SB 2035 80 (0.1–1 nmol), a p38 MAPK inhibitor. However, the Ang II type 2 (AT2) receptor antagonist PD123319, the upstream inhibitor of ERK1/2 phosphorylation U0126, and the JNK inhibitor SP600125 had no effect on Ang II-induced nociceptive behavior. Western blot analysis showed that the i.t. injection of Ang II induced phosphorylation of p38 MAPK in the lumbar dorsal spinal cord, which was inhibited by losartan, without affecting ERK1/2 and JNK. Furthermore, we found that AT1 receptor expression was relatively high in the lumbar superficial dorsal horn. Conclusions Our data show that i.t. administration of Ang II induces nociceptive behavior accompanied by the activation of p38 MAPK signaling mediated through AT1 receptors. This observation indicates that Ang II may act as a neurotransmitter and/or neuromodulator in the spinal transmission of nociceptive information.

Từ khóa


Tài liệu tham khảo

10.1152/physrev.00036.2005

de Gasparo M, 2000, Pharmacol Rev, 52, 415

Timmermans PB, 1993, Pharmacol Rev, 45, 205

10.1146/annurev.pharmtox.010909.105610

10.1161/01.CIR.88.6.2849

10.1016/j.peptides.2011.09.010

10.1016/j.peptides.2011.05.012

10.1007/978-90-481-9060-7_6

10.1016/j.pneurobio.2011.07.001

10.1016/j.mce.2009.01.019

10.1016/j.neuroscience.2008.11.044

10.1016/S0006-8993(03)02541-1

10.1016/j.neuroscience.2004.12.046

10.1016/0304-3940(93)90785-J

10.1016/j.yexcr.2012.06.015

10.1016/j.molimm.2012.02.004

10.1161/01.RES.0000185804.79157.C0

10.1038/16040

10.1523/JNEUROSCI.22-17-07737.2002

10.1016/S0304-3959(02)00097-0

10.1016/S0169-328X(03)00284-5

10.1371/journal.pmed.0030338

10.1016/S0006-8993(02)03180-3

10.1016/j.pain.2004.11.004

10.1016/S0304-3959(99)00312-7

10.1254/jphs.FP0070203

10.1016/j.npep.2006.10.003

10.1016/S0167-0115(01)00238-5

10.1161/01.HYP.36.4.549

10.1016/j.neubiorev.2003.11.008

10.1016/S0091-3057(98)00116-6

10.1016/S0196-9781(99)00040-6

10.1016/j.regpep.2010.03.004

10.1016/0024-3205(96)00527-9

10.1016/j.brainres.2008.09.099

10.1016/j.neuroscience.2009.09.004

10.1111/j.1471-4159.2005.03226.x

10.1016/j.brainresrev.2008.12.011

10.1074/jbc.273.3.1741

10.1016/j.neulet.2007.11.065

10.1213/01.ane.0000287660.29297.7b

10.1523/JNEUROSCI.23-10-04017.2003

10.1016/j.neuroscience.2008.03.041

10.1002/glia.10308

10.1186/1744-8069-4-17

10.1097/00001756-200212200-00021

10.1046/j.1471-4159.2003.01969.x

10.1016/j.pain.2004.07.007

10.1097/00001756-200306110-00010

10.1016/j.pain.2004.09.038

10.1677/JOE-07-0596

10.1016/0014-2999(80)90515-4

10.1016/S0166-4328(02)00383-2

Thông tin
Thông tin xuất bản

Molecular Pain

Tập 9

Thông tin tác giả